Vira Tseluyko
Weatherford College(US)V. N. Karazin Kharkiv National University(UA)
Publications by Year
Research Areas
Venous Thromboembolism Diagnosis and Management, Healthcare Systems and Public Health, Atrial Fibrillation Management and Outcomes, Acute Myocardial Infarction Research, Cardiac Imaging and Diagnostics
Most-Cited Works
- → Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial(2018)253 cited
- → A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy(2015)226 cited
- → A phase II, randomized, double‐blind, placebo‐controlled study evaluating the efficacy and safety of MDX‐1100, a fully human anti‐CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis(2011)195 cited
- → Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial(2012)98 cited
- → 52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis(2017)67 cited
- → Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54